OACCW

Oaktree Acquisition Corp. III Life SciencesNASDAQFinancial Services

$0.75+0.00%ClosedMarket Cap: $18.5M

As of 2026-04-06

Valuation

P/E (TTM)

2.53

PEG

—

P/B

0.07

P/S

0.00

EV/EBITDA

-22.82

DCF Value

—

FCF Yield

-1.5%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

4.8%

ROA

3.4%

ROIC

-0.4%

Income Statement

Period	Revenue	Gross Margin	Operating Income	Net Income	EPS	Dividend
Q4 2025	$0.00	NaN%	$-255.5K	$2.2M	$0.07	—
FY 2025	$0.00	NaN%	$-1.2M	$7.3M	$0.30	—
Q3 2025	$0.00	NaN%	$-225.6K	$2.0M	$0.08	—
Q2 2025	$0.00	NaN%	$-269.8K	$1.9M	$0.08	—
Q1 2025	$0.00	NaN%	$0.00	$1.3M	$0.07	—
Q4 2024	$0.00	NaN%	$-303.7K	$1.4M	$0.06	—
FY 2024	$0.00	NaN%	$-351.8K	$1.3M	$0.05	—
Q3 2024	$0.00	NaN%	$-48.1K	$-48.1K	$-0.00	—